000028 国药一致
已收盘 09-14 15:00:00
资讯
新帖
简况
股市必读:国药一致(000028)9月9日董秘有最新回复
证券之星 · 09-10
股市必读:国药一致(000028)9月9日董秘有最新回复
国药一致:该项目尚在施工中,未来会使用现代化技术设备
证券之星 · 09-09
国药一致:该项目尚在施工中,未来会使用现代化技术设备
股市必读:国药一致(000028)8月31日董秘有最新回复
证券之星 · 09-01
股市必读:国药一致(000028)8月31日董秘有最新回复
国药一致:主业优化与提质增效方面,公司持续推进组织结构优化,巩固传统分销基本盘、加快培育新增长引擎,并成立医疗器械中心、医学业务部等,强化专业化运营能力
证券之星 · 08-31
国药一致:主业优化与提质增效方面,公司持续推进组织结构优化,巩固传统分销基本盘、加快培育新增长引擎,并成立医疗器械中心、医学业务部等,强化专业化运营能力
国药一致:通过严格资信管控、专项跟踪清收、持续对账确权、强化法律催收等手段,最大限度降低坏账损失风险
证券之星 · 08-31
国药一致:通过严格资信管控、专项跟踪清收、持续对账确权、强化法律催收等手段,最大限度降低坏账损失风险
股市必读:国药一致中报 - 第二季度单季净利润同比下降5.67%
证券之星 · 08-31
股市必读:国药一致中报 - 第二季度单季净利润同比下降5.67%
每周股票复盘:国药一致(000028)2026上半年营收362.66亿
证券之星 · 08-30
每周股票复盘:国药一致(000028)2026上半年营收362.66亿
国药一致(000028)披露对国药集团财务有限公司的风险持续评估报告,8月28日股价上涨0.15%
证券之星 · 08-28
国药一致(000028)披露对国药集团财务有限公司的风险持续评估报告,8月28日股价上涨0.15%
国药控股(01099):国药一致中期归母净利润6.06亿元 同比减少8.97%
智通财经 · 08-28
国药控股(01099):国药一致中期归母净利润6.06亿元 同比减少8.97%
每周股票复盘:国药一致(000028)上半年净利降8.97%
证券之星 · 08-23
每周股票复盘:国药一致(000028)上半年净利降8.97%
股市必读:国药一致新发布《2026年半年度业绩快报》
证券之星 · 08-19
股市必读:国药一致新发布《2026年半年度业绩快报》
国药一致:扎实推进估值提升计划
证券之星 · 08-18
国药一致:扎实推进估值提升计划
国药一致2026年上半年归母净利润6.062亿元,同比下降8.97%
美股速递 · 08-17
国药一致2026年上半年归母净利润6.062亿元,同比下降8.97%
国药一致(000028.SZ)上半年归母净利润6.06亿元 同比下降8.97%
智通财经 · 08-17
国药一致(000028.SZ)上半年归母净利润6.06亿元 同比下降8.97%
国药一致(000028)披露2026年第一次临时股东会决议公告,8月10日股价上涨0.64%
证券之星 · 08-10
国药一致(000028)披露2026年第一次临时股东会决议公告,8月10日股价上涨0.64%
每周股票复盘:国药一致(000028)拟变更注册资本至6.12亿元
证券之星 · 07-26
每周股票复盘:国药一致(000028)拟变更注册资本至6.12亿元
国药一致(000028)披露召开2026年第一次临时股东会通知,7月24日股价下跌2.14%
证券之星 · 07-24
国药一致(000028)披露召开2026年第一次临时股东会通知,7月24日股价下跌2.14%
每周股票复盘:国药一致(000028)新增广州办公地址
证券之星 · 07-05
每周股票复盘:国药一致(000028)新增广州办公地址
国药一致(000028)披露新增办公地址公告,7月3日股价上涨3.09%
证券之星 · 07-03
国药一致(000028)披露新增办公地址公告,7月3日股价上涨3.09%
每周股票复盘:国药一致(000028)拟每10股派6.16元
证券之星 · 06-20
每周股票复盘:国药一致(000028)拟每10股派6.16元
加载更多
公司概况
公司名称:
国药集团一致药业股份有限公司
所属行业:
批发业
上市日期:
1993-08-09
主营业务:
国药集团一致药业股份有限公司的主营业务是医药分销和医药零售。公司的主要产品是药品、器械耗材、诊断试剂、仪器设备。
发行价格:
3.50
{"stockData":{"symbol":"000028","market":"SZ","secType":"STK","nameCN":"国药一致","latestPrice":20,"timestamp":1789369434000,"preClose":19.8,"halted":0,"volume":1577884,"delay":0,"changeRate":0.0101,"floatShares":526000000,"shares":612000000,"eps":1.7579,"marketStatus":"已收盘","change":0.2,"latestTime":"09-14 15:00:00","open":19.76,"high":20.03,"low":19.7,"amount":31451000,"amplitude":0.0167,"askPrice":20,"askSize":69,"bidPrice":19.98,"bidSize":30,"shortable":0,"etf":0,"ttmEps":1.7579,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"adjPreClose":19.8,"symbolType":"stock","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":21.78,"lowLimit":17.82,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":612221584,"isCdr":false,"pbRate":0.64,"roa":"--","peRate":11.377211,"roe":"3.21%","epsLYR":2.04,"committee":-0.408451,"marketValue":12244000000,"turnoverRate":0.003,"status":0,"floatMarketCap":10517000000},"requestUrl":"/m/hq/s/000028","defaultTab":"news","newsList":[{"id":"2666325075","title":"股市必读:国药一致(000028)9月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2666325075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666325075?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:41","pubTimestamp":1788975671,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘,国药一致报收于20.3元,下跌0.29%,换手率0.36%,成交量1.9万手,成交额3850.61万元。董秘最新回复投资者: 贵公司您好,请问下国药南沙筹建的国药生命健康产业园目前的进度如何?大概什么时候能投入运行?有无引进先进设施,ai智能技术设备等?该项目尚在施工中,未来会使用现代化技术设备。当日关注点交易信息汇总:9月9日主力资金净流出0.11万元,游资资金净流入98.95万元、占总成交额2.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000002112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0082","BK0010","BK0188","BK0250","BK0196","BK0028","BK0185","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458318","title":"国药一致:该项目尚在施工中,未来会使用现代化技术设备","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666458318?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:51","pubTimestamp":1788940294,"startTime":"0","endTime":"0","summary":"证券之星消息,国药一致(000028)09月09日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司您好,请问下国药南沙筹建的国药生命健康产业园目前的进度如何?大概什么时候能投入运行?有无引进先进设施,ai智能技术设备等?国药一致回复:感谢您的关注。该项目尚在施工中,未来会使用现代化技术设备。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900023067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0010","BK0175","BK0028","BK0188","000028","BK0185","BK0250","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664300888","title":"股市必读:国药一致(000028)8月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2664300888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664300888?lang=zh_cn&edition=full","pubTime":"2026-09-01 03:43","pubTimestamp":1788205389,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,国药一致报收于19.91元,下跌0.35%,换手率0.32%,成交量1.69万手,成交额3362.12万元。董秘最新回复投资者: 请问贵公司截至2025年末,公司应收账款规模达到215.38亿元,占总资产比例高达43.87%,2026年一季度进一步攀升至239亿元。利润分配方面,公司分红比例连续两年超30%,2025年度现金分红总额3.42亿元,占2025年度归属于上市公司股东净利润的30.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100004146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0250","000028","BK0196","BK0175","BK0082","BK0185","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663078094","title":"国药一致:主业优化与提质增效方面,公司持续推进组织结构优化,巩固传统分销基本盘、加快培育新增长引擎,并成立医疗器械中心、医学业务部等,强化专业化运营能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2663078094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663078094?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:45","pubTimestamp":1788162311,"startTime":"0","endTime":"0","summary":"主业优化与提质增效方面,公司持续推进组织结构优化,巩固传统分销基本盘、加快培育新增长引擎,并成立医疗器械中心、医学业务部等,强化专业化运营能力。利润分配方面,公司分红比例连续两年超30%,2025年度现金分红总额3.42亿元,占2025年度归属于上市公司股东净利润的30.18%。公司将继续围绕稳经营、提质效等方向增进市场认同,推动公司价值合理反映上市公司质量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100017002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","09996","000028","BK0028","BK0196","BK1583","159883","BK1574","BK0010","BK0185","BK0175","BK1100","BK0188","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663078727","title":"国药一致:通过严格资信管控、专项跟踪清收、持续对账确权、强化法律催收等手段,最大限度降低坏账损失风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2663078727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663078727?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:45","pubTimestamp":1788162310,"startTime":"0","endTime":"0","summary":"公司高度重视应收账款风险管控,业务、财务、法务等部门通力合作,高效协同,通过严格资信管控、专项跟踪清收、持续对账确权、强化法律催收等手段,最大限度降低坏账损失风险。强化业务源头管控,通过细化资信管控颗粒度,持续控增量、清存量,降低应收账款风险;升级应收账款风险预警体系,分级分类处置,响应流程更加完善;常态化实施对账确权,确保债权清晰;对高风险客户推进法律催收,保障公司权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100017000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","000028","BK0010","BK0028","BK0185","BK0250","BK0196","BK0188","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663025516","title":"股市必读:国药一致中报 - 第二季度单季净利润同比下降5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663025516","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663025516?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:19","pubTimestamp":1788139189,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年中报显示归母净利润6.06亿元,同比下降8.97%。关于对国药集团财务有限公司的风险持续评估报告截至2026年6月30日,国药集团财务有限公司资产规模484.70亿元,资本充足率16.16%,流动性比例58.03%,各项监管指标符合规定;内部控制制度健全,风险管理有效,未发现与财务报表相关的重大风险控制缺陷;公司在其存款余额21,555,649.17元,资金安全性和流动性良好。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100003524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663504385","title":"每周股票复盘:国药一致(000028)2026上半年营收362.66亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2663504385","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663504385?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:36","pubTimestamp":1788042972,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,国药一致报收于19.98元,较上周的19.47元上涨2.62%。本周,国药一致8月27日盘中最高价报20.13元。业绩披露要点国药一致2026年中报显示,上半年度公司主营收入362.66亿元,同比下降1.44%;归母净利润6.06亿元,同比下降8.97%;扣非净利润5.99亿元,同比下降6.84%。国药一致对国药集团财务有限公司开展风险持续评估。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662091339","title":"国药一致(000028)披露对国药集团财务有限公司的风险持续评估报告,8月28日股价上涨0.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662091339","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662091339?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:26","pubTimestamp":1787927217,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,国药一致报收于19.98元,较前一交易日上涨0.15%,最新总市值为122.32亿元。近日,国药集团一致药业股份有限公司发布《关于对国药集团财务有限公司的风险持续评估报告》。公告显示,国药财务公司持有有效的《金融许可证》和《企业法人营业执照》,截至2026年6月30日,资产规模为484.70亿元,资本充足率16.16%,流动性比例58.03%,各项监管指标均符合规定。国药一致在国药财务公司存款余额21,555,649.17元,资金安全性和流动性良好。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800054945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0010","BK0082","BK0028","BK0175","BK0185","BK0196","BK0188","000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066765","title":"国药控股(01099):国药一致中期归母净利润6.06亿元 同比减少8.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066765","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662066765?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:56","pubTimestamp":1787911018,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药控股(01099)发布国药一致截至2026年6月30日止六个月业绩,营业总收入362.66亿元人民币,同比减少1.44%;归属于上市公司股东的净利润6.06亿元,同比减少8.97%;基本每股收益0.99元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01099","000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661214327","title":"每周股票复盘:国药一致(000028)上半年净利降8.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661214327","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661214327?lang=zh_cn&edition=full","pubTime":"2026-08-23 03:30","pubTimestamp":1787427030,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘,国药一致报收于19.47元,较上周的20.09元下跌3.09%。本周,国药一致8月20日盘中最高价报20.25元。本周关注点来自业绩披露要点:国药一致2026年上半年归属净利润同比下降8.97%,达6.062亿元。公司公告汇总国药一致发布2026年半年度业绩快报,报告期内实现营业总收入362.66亿元,同比下降1.44%;营业利润8.34亿元,同比下降9.94%;归属于上市公司股东的净利润6.06亿元,同比下降8.97%。基本每股收益0.99元,同比下降9.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000028","BK0196","BK0082","BK0188","BK0010","BK0185","BK0250","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491310","title":"股市必读:国药一致新发布《2026年半年度业绩快报》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491310","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660491310?lang=zh_cn&edition=full","pubTime":"2026-08-19 02:22","pubTimestamp":1787077332,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘,国药一致报收于19.9元,下跌0.65%,换手率0.64%,成交量3.38万手,成交额6719.02万元。公司公告汇总:国药一致发布2026年半年度业绩快报,营业总收入362.66亿元,同比下降1.44%;归母净利润6.06亿元,同比下降8.97%。分红送股后总股本增至61222.16万股。公司始终将市值管理作为高质量发展的重要组成部分,严格落实《市值管理制度》,扎实推进估值提升计划,切实维护全体股东权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","BK0082","BK0010","000028","BK0028","BK0185","BK0250","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660457493","title":"国药一致:扎实推进估值提升计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2660457493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660457493?lang=zh_cn&edition=full","pubTime":"2026-08-18 15:09","pubTimestamp":1787036953,"startTime":"0","endTime":"0","summary":"证券之星消息,国药一致08月18日在投资者关系平台上答复投资者关心的问题。公司始终将市值管理作为高质量发展的重要组成部分,严格落实《市值管理制度》,扎实推进估值提升计划,切实维护全体股东权益。市场价值传递方面,公司持续完善投资者关系管理,通过常态化沟通机制和高质量信息披露,传递战略规划与经营成果,积极引导资本市场理性估值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800021229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0175","BK0250","000028","BK0082","BK0185","BK0028","BK0010","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184788352","title":"国药一致2026年上半年归母净利润6.062亿元,同比下降8.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184788352","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184788352?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:59","pubTimestamp":1786971550,"startTime":"0","endTime":"0","summary":"国药一致(000028.SZ)公布2026年上半年业绩报告,归属于母公司股东的净利润为6.062亿元人民币,较去年同期下滑8.97%。母公司国药控股(01099.HK)旗下这一核心医药分销平台,上半年经营表现承压,盈利能力有所收窄。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000028","BK0188","BK0175","BK0250","BK0010","BK1197","01099","BK1500","BK0196","BK1515","LU0640798160.USD","LU1115378108.SGD","BK0028","BK0082","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482194","title":"国药一致(000028.SZ)上半年归母净利润6.06亿元 同比下降8.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482194","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660482194?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:48","pubTimestamp":1786967296,"startTime":"0","endTime":"0","summary":"零售板块实现营业收入102.27亿元,同比下降2.40%,降幅有所收窄;实现净利润0.13亿元,同比下降19.74%。受行业政策调整、市场竞争加剧等因素影响,国大药房销售收入略有下滑;叠加销售结构变动,高毛利品种销售占比降低,毛利额减少,导致利润下降。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658937899","title":"国药一致(000028)披露2026年第一次临时股东会决议公告,8月10日股价上涨0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658937899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658937899?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:37","pubTimestamp":1786372638,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘,国药一致报收于20.45元,较前一交易日上涨0.64%,最新总市值为125.2亿元。该股当日开盘20.35元,最高20.72元,最低20.28元,成交额达8391.94万元,换手率为0.78%。近日,国药集团一致药业股份有限公司发布2026年第一次临时股东会决议公告。公告显示,公司于2026年8月10日召开2026年第一次临时股东会,会议采用现场投票与网络投票相结合的方式进行,出席会议股东及代理人共212人,代表股份占公司有表决权总股份的59.3579%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0082","BK0010","BK0188","BK0250","BK0196","BK0028","BK0185","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654105778","title":"每周股票复盘:国药一致(000028)拟变更注册资本至6.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654105778","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654105778?lang=zh_cn&edition=full","pubTime":"2026-07-26 03:04","pubTimestamp":1785006255,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,国药一致报收于20.16元,较上周的20.78元下跌2.98%。本周关注点公司公告汇总:国药一致拟变更注册资本至61,222.1584万元,因利润分配送股导致总股本增至612,221,584股。会议将审议变更注册资本及修订《公司章程》、选举独立董事、2026年度董事薪酬方案三项议案,其中第一项为特别决议事项。因实施2025年度利润分配方案,公司以每10股送红股1股方式增加股本,总股本由556,565,077股增至612,221,584股,注册资本由55,656.5077万元增至61,222.1584万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600001004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0250","BK0175","000028","BK0028","BK0196","BK0188","BK0082","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653503315","title":"国药一致(000028)披露召开2026年第一次临时股东会通知,7月24日股价下跌2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653503315","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653503315?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:46","pubTimestamp":1784904379,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,国药一致报收于20.16元,较前一交易日下跌2.14%,最新总市值为123.42亿元。该股当日开盘20.46元,最高20.72元,最低20.16元,成交额达5054.02万元,换手率为0.47%。近日,国药集团一致药业股份有限公司发布《关于召开2026年第一次临时股东会的通知》。公告显示,公司将于2026年8月10日召开2026年第一次临时股东会,会议由董事会召集,现场会议地点为深圳市福田区八卦四路15号一致药业大厦5楼会议室。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0010","000028","BK0188","BK0185","BK0196","BK0250","BK0082","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649692634","title":"每周股票复盘:国药一致(000028)新增广州办公地址","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692634","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649692634?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:46","pubTimestamp":1783194372,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,国药一致报收于20.36元,较上周的19.1元上涨6.6%。本周,国药一致7月3日盘中最高价报20.38元。本周关注点公司公告汇总:国药一致新增广东省广州市荔湾区站前路22号医药大厦11楼为办公地址。公司公告汇总国药集团一致药业股份有限公司因管理需要,在广东省广州市新增一处办公地址,并更新了董事会秘书联系电话和公司传真。公司注册地址、电子邮箱等其他信息保持不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0175","BK0250","BK0082","000028","BK0196","BK0010","BK0185","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648664852","title":"国药一致(000028)披露新增办公地址公告,7月3日股价上涨3.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648664852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648664852?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:46","pubTimestamp":1783089983,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,国药一致报收于20.36元,较前一交易日上涨3.09%,最新总市值为124.65亿元。该股当日开盘19.72元,最高20.38元,最低19.69元,成交额达7556.66万元,换手率为0.72%。公告显示,公司因管理需要,在广东省广州市新增一处办公地址,并更新了董事会秘书联系电话和公司传真。公司注册地址、电子邮箱等其他信息保持不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300046041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0250","000028","BK0082","BK0028","BK0188","BK0175","BK0010","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644470065","title":"每周股票复盘:国药一致(000028)拟每10股派6.16元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644470065","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644470065?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:09","pubTimestamp":1781896191,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,国药一致报收于22.6元,较上周的22.65元下跌0.22%。本周,国药一致6月15日盘中最高价报22.85元。本周关注点公司公告汇总:国药一致拟每10股派现金红利6.16元(含税),同时每10股送红股1股。公司公告汇总国药集团一致药业股份有限公司2025年年度权益分派方案已获股东会审议通过,以总股本556,565,077股为基数,向全体股东每10股派现金红利6.116元(含税),每10股送红股1股,不进行资本公积金转增股本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000001885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0028","BK0196","BK0175","BK0188","BK0250","BK0185","BK0010","BK0082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789428211136,"stockEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":-0.0045},{"period":"3month","weight":0.0042},{"period":"6month","weight":-0.1346},{"period":"1year","weight":-0.1225},{"period":"ytd","weight":-0.0797}],"compareEarnings":[{"period":"1week","weight":-0.012},{"period":"1month","weight":-0.0107},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0038},{"period":"ytd","weight":-0.021}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国药集团一致药业股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"0人","perCapita":"--","listingDate":"1993-08-09","address":"广东省深圳市福田区园岭街道八卦四路15号一致药业大厦","registeredCapital":"61222万元","survey":" 国药集团一致药业股份有限公司的主营业务是医药分销和医药零售。公司的主要产品是药品、器械耗材、诊断试剂、仪器设备。","listedPrice":3.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药一致,000028,国药一致股票,国药一致股票老虎,国药一致股票老虎国际,国药一致行情,国药一致股票行情,国药一致股价,国药一致股市,国药一致股票价格,国药一致股票交易,国药一致股票购买,国药一致股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}